SoylentNews is people
SoylentNews
A recall for EpiPens will now extend to Asia, Europe, North America, and South America:
Generic drugmaker Mylan NV said on Friday that its manufacturing partner for EpiPen devices had expanded a recall of the life-saving allergy shot in the United States and other markets.
The announcement comes a week after Mylan said it had recalled about 81,000 EpiPen devices in countries outside the United States following two reports of the company's allergy treatment failing to work in emergencies.
[Ed. Note: This recall is limited to some lot numbers distributed in late 2015 and early-to-mid 2016. More information at the US FDA website.]
This discussion has been archived.
No new comments can be posted.
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
Fascinating is a word I use for the unexpected.
-- Spock, "The Squire of Gothos", stardate 2124.5
(Score: 2, Insightful) by Anonymous Coward on Sunday April 02 2017, @10:44PM (2 children)
Not only a rip-off, but defective...
(Score: 1, Touché) by Anonymous Coward on Sunday April 02 2017, @11:05PM (1 child)
Expect a 25000% price increase to cover the recall.
(Score: 2) by takyon on Monday April 03 2017, @12:40AM
Make it yourself:
"Pharmaceutical Hacker" Releasing Plans for "Open-Source Drugs" [soylentnews.org]
About one of the only things that group has done when I submitted that article was to create "open source" plans for a DIY $30 EpiPen injector.
[SIG] 10/28/2017: Soylent Upgrade v14 [soylentnews.org]